摘要
目的 回顾性分析2007―2020年武汉市耐药肺结核高危人群耐药流行趋势。方法 对2007年1月1日―2020年12月31日武汉市新登记的5 139例耐药肺结核高危人群进行筛查,采用描述性研究、趋势χ^(2)检验和多因素非条件logistic回归分析模型进行统计分析。结果 武汉市耐药肺结核高危人群结核分枝杆菌总耐药率为35.51%(1 600/4 506),6种抗结核药物的任何耐药频度依次为:异烟肼(isoniazid,H)>利福平(rifampin,R)>链霉素(streptomycin,S)>氧氟沙星(ofloxacin,O)>乙胺丁醇(ethambutol,E)>卡那霉素(Kanamycin,K)。2007―2020年除O耐药率外,总耐药率、耐多药率和H、R、S、E、K耐药率均呈上升趋势(R耐药率:P=0.002,其余均有P<0.001)。2015―2020年耐药、耐多药、H、E、S、O、K耐药率均无上升趋势,R耐药率呈上升趋势(P=0.002)。结论 2007―2020年武汉市耐药肺结核高危人群耐药疫情呈上升趋势。虽然2015―2020年未呈上升趋势,但仍迫切需要加强对此类人群的管理和控制。
Objective To retrospectively analyze the drug resistance prevalence trend of drug resistance-tuberculosis(DR-TB) high-risk populations in Wuhan from 2007 to 2020.Methods From January 1,2007 to December 31,2020,a total of 5 139 at risk individuals of DR-TB newly registered in Wuhan were screened.By carrying out a descriptive study,χ^(2) test and multivariate unconditional logistic regression,the prevalence trend and influencing factors of drug resistance were analyzed.Results The overall drug resistance rate among these individuals was 35.51%(1 600/4 506).The ranking of resistance rates of six different anti-TB drugs was as following,Isoniazid(H)>Rifampin(R)>Streptomycin(S)>Ofloxacin(O)>ethambutol(E)>Kanamycin(K).From 2007 to 2020,except the O resistance rate,the overall drug resistance rate,multidrug resistance rate,drug resistance rates of H,R,E,S and K showed an upward trend( R resistance rate:P=0.002,all the others have P<0.001).From 2015 to 2020,except an upward trend was observed in R resistance rate(P=0.002),the overall drug resistance rate,multidrug resistance rate and drug resistance rates of H,E,S,O and K remained stable.Conclusions From 2007 to 2020,an upward trend of drug resistance among Wuhan’s DR-TB at risk populations was observed.Although no upward trend was observed in the period between 2015 and 2020,further strengthening of management and control of such groups is still urgently needed.
作者
王坚杰
周美兰
任欣
吴刚
张正斌
田丹
王晓君
李月华
WANG Jian-jie;ZHOU Mei-lan;REN Xin;WU Gang;ZHANG Zheng-bin;TIAN Dan;WANG Xiao-jun;LI Yue-hua(Department of the TB Control,Wuhan Pulmonary Hospital,Wuhan 430030,China)
出处
《中华疾病控制杂志》
CAS
CSCD
北大核心
2022年第11期1353-1359,共7页
Chinese Journal of Disease Control & Prevention
基金
湖北省卫生健康委科研项目(WJ2021F011)。
关键词
分枝杆菌
结核
抗药性
趋势
影响因素
Mycobacterium
Tuberculosis
Drug resistance
Trend
Influential factors